Neogen - 31 Year Stock Price History | NEOG
Historical daily share price chart and data for Neogen since 1994 adjusted for splits and dividends. The latest closing stock price for Neogen as of March 25, 2025 is 8.45.
- The all-time high Neogen stock closing price was 48.34 on April 20, 2021.
- The Neogen 52-week high stock price is 18.58, which is 119.9% above the current share price.
- The Neogen 52-week low stock price is 8.44, which is 0.1% below the current share price.
- The average Neogen stock price for the last 52 weeks is 13.84.
| Neogen Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 10.6090 | 11.9400 | 13.0700 | 8.4500 | 8.4500 | -30.40% |
| 2024 | 15.2603 | 20.3500 | 20.3500 | 11.6100 | 12.1400 | -39.63% |
| 2023 | 18.8983 | 15.2600 | 23.8400 | 14.6500 | 20.1100 | 32.04% |
| 2022 | 24.2175 | 44.3700 | 44.3700 | 10.7900 | 15.2300 | -66.46% |
| 2021 | 43.6165 | 39.2050 | 48.3350 | 38.8500 | 45.4100 | 14.53% |
| 2020 | 35.5405 | 32.4400 | 40.9450 | 27.0100 | 39.6500 | 21.51% |
| 2019 | 31.8256 | 28.4550 | 39.4000 | 27.0800 | 32.6300 | 14.49% |
| 2018 | 35.2733 | 30.0800 | 48.2500 | 26.3600 | 28.5000 | -7.55% |
| 2017 | 26.1123 | 24.6413 | 31.6163 | 22.3726 | 30.8288 | 24.56% |
| 2016 | 20.3300 | 20.4901 | 25.4551 | 16.7325 | 24.7501 | 16.77% |
| 2015 | 18.9413 | 18.2925 | 22.7438 | 15.8888 | 21.1951 | 13.97% |
| 2014 | 15.8523 | 16.5825 | 18.5963 | 13.6163 | 18.5963 | 8.51% |
| 2013 | 14.2025 | 11.4000 | 19.0800 | 11.3275 | 17.1375 | 51.26% |
| 2012 | 9.9334 | 7.8725 | 11.9825 | 7.6525 | 11.3300 | 47.91% |
| 2011 | 9.6026 | 10.5650 | 11.9500 | 7.5350 | 7.6600 | -25.32% |
| 2010 | 7.2719 | 6.0875 | 10.4825 | 5.2175 | 10.2575 | 73.78% |
| 2009 | 4.5315 | 4.3533 | 6.0850 | 2.9883 | 5.9025 | 41.77% |
| 2008 | 4.2642 | 4.4883 | 5.1983 | 3.3317 | 4.1633 | -5.91% |
| 2007 | 3.2962 | 2.5500 | 4.5633 | 2.3611 | 4.4250 | 79.39% |
| 2006 | 2.3284 | 2.2656 | 2.7489 | 1.9422 | 2.4667 | 5.72% |
| 2005 | 1.9007 | 2.4231 | 2.4278 | 1.3889 | 2.3333 | -7.29% |
| 2004 | 2.1391 | 2.3256 | 2.5167 | 1.7589 | 2.5167 | 14.30% |
| 2003 | 1.5409 | 1.2222 | 2.4337 | 1.0604 | 2.2018 | 65.69% |
| 2002 | 1.2592 | 1.6542 | 1.6720 | 1.0213 | 1.3289 | -17.40% |
| 2001 | 1.2687 | 0.7333 | 2.2391 | 0.7333 | 1.6089 | 122.78% |
| 2000 | 0.6010 | 0.4667 | 0.8556 | 0.4612 | 0.7222 | 54.75% |
| 1999 | 0.5995 | 0.6167 | 0.8000 | 0.4444 | 0.4667 | -25.66% |
| 1998 | 0.7798 | 1.0889 | 1.2338 | 0.5111 | 0.6278 | -37.94% |
| 1997 | 0.7964 | 0.6556 | 1.2889 | 0.5778 | 1.0116 | 58.29% |
| 1996 | 0.6145 | 0.4444 | 0.7833 | 0.4222 | 0.6391 | 43.81% |
| 1995 | 0.6012 | 0.5667 | 0.7333 | 0.4333 | 0.4444 | -25.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.261B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |